Press Releases Items Per Page 102550 Year None20222021202020192018201720162015201420132012201120102007 09.05.18 Syndax to Present at the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer 08.28.18 Syndax Announces Participation at Three Upcoming Investor Conferences 08.07.18 Syndax Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Clinical and Business Update 07.31.18 Syndax to Announce Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018 05.30.18 Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration 05.30.18 Syndax Pharmaceuticals Announces Participation at Two Upcoming Investor Conferences 05.17.18 Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) 05.08.18 Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update 05.01.18 Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018 04.25.18 Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting 04.13.18 Syndax to Present at the 2018 American Association for Cancer Research Annual Meeting 03.05.18 Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update Pagination First page « first Previous page ‹ previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page next › Last page last »
09.05.18 Syndax to Present at the International Association for the Study of Lung Cancer 19th World Conference on Lung Cancer
08.07.18 Syndax Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Clinical and Business Update
07.31.18 Syndax to Announce Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 7, 2018
05.17.18 Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab)
05.08.18 Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update
05.01.18 Syndax to Announce First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 8, 2018
04.25.18 Syndax Pharmaceuticals Announces Presentations at the 2018 American Society of Clinical Oncology Annual Meeting
03.05.18 Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update
